Vinge has advised Terranor Group AB (publ) (“Terranor”) connection with its listing on Nasdaq First North Growth Market. The first day of trading in Terranor's shares is today 30 June 2025.

The offering price was SEK 20 per share, corresponding to a total market value for all shares in Terranor of SEK 400 million. The total value of the offering amounts to SEK 115 million, provided that the overallotment option is exercised in full.

Terranor is one of the leading players in road maintenance in the Nordic region. The company’s business concept is to offer a wide range of qualified services in road operation and maintenance to ensure that roads remain accessible and functional all year round. The business covers both winter road maintenance, with snow removal and anti-slip protection, and summer maintenance, such as repairs and asphalt work. In addition, Terranor offers services in green area management, road safety and light infrastructure projects.

Vinge’s team primarily consisted of David Andersson, Joel Magnusson, Anna Svensson, Karin Karsten, Johannes Akyol, Sara Franson and Elias Kröger (Capital Markets), Jonas Bergström and Fredrik Eriksson Oppliger (M&A), Hanna Lemne and Julia Rydin (EU, Competition and Regulatory), Calle Tengwall Pagels and Katja Häglund (Financing), Mario Saad, Carla Håkansson, Sara Link and Filippa Eriksson (Commercial agreements, IT and GDPR), Niclas Lindblom (Construction Law), Alice Göransson (Labor Law), Hayaat Ibrahim (Compliance), Hanna Kövamees (Real Estate Law) and Melinda Oldenburg (IP).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026